ArticlePLOS global public health2023
Determining the rate of infectious disease testing through contagion potential.
Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Dynamic contagion potential framework for optimizing infection control in healthcare.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of new strains, varying in transmissibility, virulence, and presentation, makes the existing epidemiological statistics an inadequate representation of COVID-19 contagion. Asymptomatic individuals continue to act as carriers for the elderly and immunocompromised, making the timing and extent of vaccination and testing extremely critical in curbing contagion. In our earlier work, we proposed contagion potential (CP) as a measure of the infectivity of an individual in terms of their contact with other infectious individuals. Here we extend the idea of CP at the level of a geographical region (termed a zone). We estimate CP in a spatiotemporal model based on infection spread through social mixing as well as SIR epidemic model optimization, under varying conditions of virus strains, reinfection, and superspreader events. We perform experiments on the real daily infection dataset at the country level (Italy and Germany) and state level (New York City, USA). Our analysis shows that CP can effectively assess the number of untested (and asymptomatic) infected and inform the necessary testing rates. Finally, we show through simulations that CP can trace the evolution of the infectivity profiles of zones due to the combination of inter-zonal mobility, vaccination policy, and testing rates in real-world scenarios.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.